It has been reported that rebamipide, used in Japan for the treatment of gastric ulcers and other gastrointestinal disorders, inhibited the DSS-induced IRF3 upregulation (Ogasawara et al., 2011). The gene discussed is IRF3; the disease is digestive system disorder.